Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Nov 18;74(9):1396–1407. doi: 10.1093/gerona/gly261

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2018. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

PMC Copyright notice

Figure 7. — Telomere length and telomerase activity of adipose-derived stem cells (ADSC). (A) Representative microscopic images, showing morphology of wild-type ADSC, KL-/-ADSC, and KL^-/-ADSC treated with 3 or 6 µM cycloastragenol (CAG). (B) Southern blot assay showing the telomere length size for untreated and treated samples with CAG. The blot-grid image was used for Telomere Restriction Fragment (TRF) calculation (C) Chemical structure of the CAG compound used for treatment. (D,E) Telomerase activity, and (F,G) Metabolic activity of the untreated and CAG-treated samples. (H) PCR and (I) western blot of telomerase activity in the untreated and CAG-treated samples.